Skip to main content
OpenTrials
Completed

NCT Number: NCT07455591

A Trial of Intraoperative Fibrin Sealant on Postoperative Recovery After Total Knee Replacement

This study is conducted as a pilot trial to assess the added benefit of the VeraSeal fibrin sealant to TXA on postoperative outcomes following TKR. Informed consent is obtained from all participants prior to inclusion in the study. Patients are prospectively recruited from a consecutive series of TKR procedures performed for end-stage osteoarthritis. Recruited patients were randomised into two cohorts: those receiving intra-articular tranexamic acid (TXA) alone, and those receiving intra-articular TXA and VeraSeal fibrin sealant (TXA+Sealant). Randomisation is performed just prior to surgery using a digital random allocation generator by the surgical team. Patients and physiotherapists responsible for outcome data collection are blinded to group allocation throughout the study period.

Intraoperative administration of the sealant is performed after prosthetic implantation, which was followed by topical intra-articular TXA. In the TXA group, TXA is applied intraoperatively into the joint capsule prior to closure. In the TXA+Sealant group, VeraSeal was applied evenly onto subcutaneous tissues, synovium and exposed bony surfaces within the joint capsule and allowed to cure. The same dose of topical TXA was infiltrated after VeraSeal had cured, prior to closure. All other pathways were standard per hospital protocols.

Preoperatively, demographic data including age, sex, height, and weight, as well as serum haemoglobin (Hb) levels were collected for all patients. Primary outcomes were collected on postoperative day 1: serum Hb, knee flexion range of motion (°), ambulation distance (m), and rest and ambulatory pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain) were collected. All patients were inpatient during primary outcome data collection. Secondary outcomes included: Oxford Knee Score (0-48, higher is better), American Knee Society Score (0-100, higher is better), and SF-36 Score (0-100, higher is better), collected pre-operatively and 6 months post-operatively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Singapore General Hospital Department of Orthopaedics

Singapore

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fits clinically-assessed criteria for total knee replacement

Treatment and study plan

Fibrin Sealant

Drug

Fibrin sealant contains human thrombin and fibrinogen, aiding platelet activation, aggregation, and fibrin clot formation.

Tranexamic acid (TXA)

Drug

Topical Tranexamic Acid (TXA) is an antifibrinolytic agent which stabilises clot formation and is infiltrated into local tissues perioperatively prior to closure.

Primary outcomes

  1. Serum Hb

    Time frame: Preoperatively and one day after surgery

    Serum Haemoglobin (g/dL)

  2. Knee Flexion ROM

    Time frame: Preoperatively and one day after surgery

    Knee flexion range of motion (°)

  3. Ambulation Distance

    Time frame: One day after surgery

    Ambulation distance (m)

  4. Rest Pain Score

    Time frame: One day after surgery

    Rest pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain)

  5. Ambulatory Pain Score

    Time frame: One day after surgery

    Ambulatory pain visual analogue scales (VAS) between 0 (no pain) and 10 (worst pain)

Secondary outcomes

  1. PROMs - OKS

    Time frame: Pre-operatively and 6 months post-operatively

    Oxford Knee Score (0-48, higher is better)

  2. PROMs - AKSS

    Time frame: 6 months post-operatively

    American Knee Society Score (0-100, higher is better)

  3. PROMs - SF-36

    Time frame: 6 months post-operatively

    SF-36 Score (0-100, higher is better)

Other outcomes

  1. Age

    Time frame: Preoperatively

    Age in years

  2. Sex

    Time frame: Preoperatively

    Sex

  3. BMI

    Time frame: Preoperatively

    Height and weight summarised to BMI (kg/m2)

Sponsors and collaborators

Lead sponsor

Singapore General Hospital

Other

Registry information

Official study title

A Prospective Randomised Pilot Trial Of The Supplemental Use Of Intraoperative Fibrin Sealant Alongside TXA On Postoperative Recovery After Total Knee Replacement

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Mar 6, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.